Skip to main content
. 2009 Sep 8;53(11):4816–4824. doi: 10.1128/AAC.00085-09

FIG. 4.

FIG. 4.

Relationship between ganciclovir exposure (AUC) and estimated CLCR in SOT patients after administration of i.v. ganciclovir (left) and oral valganciclovir (right) according to the manufacturer's recommended dosage. Vertical lines show dosage adjustments based on CLCR. Horizontal lines show the AUCtarget value that was considered efficacious.